News

Patients recovering from lung cancer surgery may face prolonged hospital stays when wildfires strike, according to new research examining the effects of wildfire disasters on post-operative recovery.

A new randomized controlled trial has found that combining transcranial direct current stimulation (tDCS) with aerobic exercise (AE) significantly reduces cigarette cravings and consumption in chronic smokers.

A capacitive biosensor has been developed that offers real-time airborne detection of avian influenza H5N1 and E. coli, providing a rapid, sensitive tool for disease surveillance.

The psychometric properties of the Scleroderma Skin Questionnaire (SSQ), a novel patient-reported outcome (PRO) designed to assess skin disease in patients with systemic sclerosis (SSc), has been evaluated in a new study.

Respiratory syncytial virus (RSV) transmission in U.S. households was examined in a new study that showed young children are the primary drivers of infection, spreading the virus to adults and other household members.

Cognitive decline in relapsing-remitting multiple sclerosis (RRMS) can progress independently of both relapses and MRI-detected disease activity, challenging traditional methods of monitoring MS progression, according to the results of a new study.

A deep learning model offering a powerful tool for predicting how patients with advanced non-small cell lung cancer (NSCLC) will respond to immune checkpoint inhibitors (ICIs), potentially improving treatment personalization, has been newly developed.

A 12-month interim analysis of the AGILE Phase III open-label extension study confirms that twice-yearly depemokimab, an ultra-long-acting anti-IL-5 biologic, maintains a favorable safety and efficacy profile in patients with type 2 asthma.